55.98 USD
↘ 1.69 (2.93%)AT CLOSE (03:59 PM EDT)
Travere Therapeutics, Inc. Common Stock
TVTXNASDAQ • USD
56.01
↗ 0.03 (0.04%)
POST MARKET (AS OF 04:20 PM EDT)
Post Market
AS OF 04:20 PM EDT
56.01
↗ 0.03 (0.04%)
Market: OPEN
Travere Therapeutics, Inc. Common Stock (TVTX) trades at $56.01 per share. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". This is driven by negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation front, TVTX trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Oct 5, 2026.
Open?$57.86
High?$58.77
Low?$55.16
Prev. Close?$57.67
Volume?3.1M
Avg. Volume?1.5M
VWAP?$56.05
Rel. Volume?2.01x
Bid / Ask
Bid?$48.26 × 100
Ask?$67.06 × 100
Spread?$18.80
Midpoint?$57.66
Valuation & Ratios
Market Cap?5.4B
Shares Out?94.3M
Float?90.2M
Float %?95.6%
P/E Ratio?N/A
P/B Ratio?221.68
EPS?-$0.46
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.
Themes
Address
3611 VALLEY CENTRE DR
SAN DIEGO, CA 92130
Phone: 888-969-7879
SAN DIEGO, CA 92130
Phone: 888-969-7879
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?64
Momentum?57
Short Sent.?23
Piotroski F-Score?3/9Weak
Altman Z-Score?2.77Grey
Confidence?70%Moderate
Short InterestVery High
Short % of Float?14.37%High
Short Interest?13.0M
Days to Cover?10.4
Free Float90.2M
Avg Daily Volume1.2M
Settlement Date2026-09-15
Financial Health
Current Ratio?4.05Strong
Quick Ratio?3.99Strong
Cash Ratio?0.77Adequate
Debt/Equity?24.58High
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score33/100
P/E?N/A▾
P/B?221.68HIGH▾
Peers100
S&P3
P/S?9.19HIGH▾
Peers100
S&P9
P/FCF?58.8PRICEY▾
Peers100
S&P8
EV/EBITDA?258.4HIGH▾
Peers100
S&P3
EV/Sales?10.01HIGH▾
Peers100
S&P11
Returns & Efficiency
ROE?-177.2%WEAK▾
S&P3
ROA?-5.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$92.5M
Enterprise Value?$5.9B
Fundamentals ratios updated end of day